serine/threonine Kinase 17a (STK17A) Peptide
STK17A
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all STK17A products
- STK17A (serine/threonine Kinase 17a (STK17A))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-STK17A antibody (Catalog #: AVARP02028_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- STK17A (serine/threonine Kinase 17a (STK17A))
- Synonyms
- STK17A Peptide, DRAK1 Peptide, RDRAK1 Peptide, serine/threonine kinase 17a Peptide, serine/threonine kinase 17a L homeolog Peptide, STK17A Peptide, stk17a Peptide, stk17a.L Peptide
- Background
-
STK17A belongs to the protein kinase superfamily, CAMK Ser/Thr protein kinase family, DAP kinase subfamily. It contains 1 protein kinase domain. STK17A acts as a positive regulator of apoptosis.This gene is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity.
Alias Symbols: DRAK1
Protein Interaction Partner: STK17A,STK17A
Protein Size: 414 - Molecular Weight
- 46 kDa
- Gene ID
- 9263
- NCBI Accession
- NM_004760, NP_004751
- UniProt
- Q9UEE5
-
You are here:
